Address
Email address
https://cranfeld.comCranfeld - CranfeldCranfeld Clinicu eesmärk on teostada kvaliteetseid ja kiireid terviseuuringuid, et aidata avastada varakult võimalikke tervisemuresid.
Name
Kesk 7 kinnisvara OÜ
Registry code
16158737
VAT number
EE102339996
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
10.02.2021 (3)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
68201 - Rental and operating of own or leased real estate
-
-19 447 €
-
-
4 959 €
0
Submitted
No tax arrears
-392%
-7%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Christal Investments OÜ 16266556 | 51% - 1 275.00 EUR | - | - | |
| Ueesti Holdings OÜ 16066120 | 49% - 1 225.00 EUR | - | - | |
| Karl Axel Fredrik Gyllenhammar 08.03.1951 (73) | - | Board member | Indirect ownership | |
| Michael Christopher Gagne 23.12.1966 (57) | - | - | Indirect ownership | |
| Tarmo Laanetu 12.12.1974 (49) | - | - | Indirect ownership | |
| FG Holding OÜ 12783125 | - | - | - | Founder |
| 2021 22.02.2022 | 2022 26.04.2023 | 2023 30.06.2024 | |
|---|---|---|---|
| Total Revenue | - | - | - |
| Net profit (loss) for the period | -8 814 € | -20 280 € | -19 447 € |
| Profit Margin | - | - | - |
| Current Assets | 28 679 € | 25 059 € | 15 413 € |
| Fixed Assets | 243 519 € | 246 138 € | 254 332 € |
| Total Assets | 272 198 € | 271 197 € | 269 745 € |
| Current Liabilities | 25 338 € | 286 791 € | 264 786 € |
| Non Current Liabilities | 253 174 € | 0 € | - |
| Total Liabilities | 278 512 € | - | - |
| Share Capital | - | - | - |
| Equity | -6 314 € | -15 594 € | 4 959 € |
| Employees | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | 112.62 € | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | 112.63 € | - | - |
| 2022 Q4 | - | 112.62 € | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | 112.63 € | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
